These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 8207673)
1. Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides. Schmidt DE; Votaw JR; Kessler RM; de Paulis T J Pharm Sci; 1994 Mar; 83(3):305-15. PubMed ID: 8207673 [TBL] [Abstract][Full Text] [Related]
2. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Mukherjee J; Yang ZY; Das MK; Brown T Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142 [TBL] [Abstract][Full Text] [Related]
3. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners. Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158 [TBL] [Abstract][Full Text] [Related]
4. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. de Paulis T; Kumar Y; Johansson L; Rämsby S; Florvall L; Hall H; Angeby-Möller K; Ogren SO J Med Chem; 1985 Sep; 28(9):1263-9. PubMed ID: 4040977 [TBL] [Abstract][Full Text] [Related]
5. Influence of substituents in fluorobenzene derivatives on the cytochrome P450-catalyzed hydroxylation at the adjacent ortho aromatic carbon center. Koerts J; Velraeds MM; Soffers AE; Vervoort J; Rietjens IM Chem Res Toxicol; 1997 Mar; 10(3):279-88. PubMed ID: 9084907 [TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamide drug models. Clark CR; Garcia-Roura LE J Chromatogr Sci; 1989 Mar; 27(3):111-7. PubMed ID: 2708496 [TBL] [Abstract][Full Text] [Related]
7. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands. Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126 [TBL] [Abstract][Full Text] [Related]
8. Impact of Fluoroalkyl Substituents on the Physicochemical Properties of Saturated Heterocyclic Amines. Melnykov KP; Tavlui O; Skreminskiy A; Kuchkovska YO; Grygorenko OO Chemistry; 2022 Oct; 28(55):e202201601. PubMed ID: 35699162 [TBL] [Abstract][Full Text] [Related]
9. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study. Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships of salicylamide neuroleptic agents. Gupta SP; Saha RN; Singh P Drug Des Deliv; 1990 May; 6(1):41-7. PubMed ID: 1981828 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist. Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853 [TBL] [Abstract][Full Text] [Related]
12. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT. Chumpradit S; Kung MP; Billings J; Mach R; Kung HF J Med Chem; 1993 Jan; 36(2):221-8. PubMed ID: 8093734 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand. Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586 [TBL] [Abstract][Full Text] [Related]
14. Molecular and crystal structure of the hydrochloride monohydrate of (R)-N-[[1-(4-fluorobenzyl)-2-pyrrolidinyl]methyl]-5-bromo-2,3- dimethoxybenzamide, NCQ 115, a novel dopamine D2 receptor antagonist. Csöregh I; Högberg T Acta Pharm Nord; 1992; 4(1):1-4. PubMed ID: 1387534 [TBL] [Abstract][Full Text] [Related]
15. Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives. Estour F; Ferranti V; Chabenat C; Toussaint E; Galons H; Lafont O J Pharm Biomed Anal; 2007 Oct; 45(2):237-42. PubMed ID: 17656059 [TBL] [Abstract][Full Text] [Related]
16. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors. de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140 [TBL] [Abstract][Full Text] [Related]
17. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride. Clark CR; Smith FT; Clark MR; Garcia-Roura LE J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors. Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895 [TBL] [Abstract][Full Text] [Related]
19. Octanol/water partition coefficient of ortho-substituted aromatic solutes. Sotomatsu T; Shigemura M; Murata Y; Fujita T J Pharm Sci; 1993 Aug; 82(8):776-81. PubMed ID: 8377112 [TBL] [Abstract][Full Text] [Related]
20. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation. Sabbioni G Chem Biol Interact; 1992 Jan; 81(1-2):91-117. PubMed ID: 1730150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]